STAT Plus: As the market craters, Keros Therapeutics files for an IPO

Keros Therapeutics is filing for an IPO, according to plans made public Monday — a bold move amid the stock market’s historic nose dive. But it may need to be bold: Until a few days ago, the Lexington, Mass.-based company was very nearly out of money.

The company raised $56 million in a recent Series C financing — but it estimates that without that funding, it wouldn’t have lasted more than a few months, according to the prospectus for its initial public offering. The company confidentially filed the paperwork for its offering on Jan. 21.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: As the market craters, Keros Therapeutics files for an IPO »